Oncocyte Corp (OCX) Live Share Price, Invest From India

Oncocyte Corp Stock Performance

as on June 18, 2025 at 6:59 am IST

$3.17
Day's Price Range
$3.17
$3.17
52 Week's Low
52 Week's High
$2.56
52-Week Price Range
$3.50
$3.17
19.24%
Downside
10.41%
Upside

Oncocyte Corp share price movements today

Previous Close: $2.73
Open: $3.17
Volume: 3.5K
Day's Low - High: $3.17 - $3.17
52 Week Low - High: $2.56 - $3.50

Oncocyte Corp Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Oncocyte Corp Stock Fundamentals & Key Indicators

Check Oncocyte Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

0.00%

Oncocyte Corp stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Oncocyte Corp with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Oncocyte Corp	BUY	$-	NA	NA	0.00%

Analyst Recommendation on Oncocyte Corp Stock

Based on 8 analysts

BUY

62.50%

Buy

37.50%

Hold

0.00%

Sell

Based on 8 analysts, 62.5% of analysts recommend a 'BUY' rating for Oncocyte Corp. Average target price of $5.42

Oncocyte Corp Share Price Target

Get share price movements and forecasts by analysts on Oncocyte Corp.

What analysts predicted

41.51%UPSIDE

Target Price

$5.42

Current Price

$3.17

Analyzed by

8 Analysts

Target

$5.42

Oncocyte Corp target price $5.42, a slight upside of 41.51% compared to current price of $3.17. According to 8 analysts rating.

Oncocyte Corp Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Total Revenue	0	0	0	0	0	0	0	0	1	2
Gross Profit	0	0	0	0	0	0	0	0	0	1
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-44	-45	-8	-6	-15	-9	-4	-13	-33	-6
Net Profit Margin	-16415.33%	-15264.31%	-1799.78%	-1512.59%	-5092.99%	-5186.93%	-4355.77%	-11733.04%	-2255.11%	-312.02%

Oncocyte Corp Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	0	1	7	0	1	1
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-8	-11	-19	-15	-22	-29	-64	-73	-27	-60
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-139556.25%	-2461.51%	-829.52%	-7665.97%	-1848.37%	-3225.04%

Global Institutional Holdings in Oncocyte Corp

Funds	Holdings
BROADWOOD CAPITAL Inc	39.9%
Awm Investment Company Inc	9.87%
PURA VIDA INVESTMENTS, LLC	3.31%
Vanguard Group Inc	0.93%
Geode Capital Management, LLC	0.56%

See all

About Oncocyte Corp

Oncocyte Corporation is a precision diagnostics company. The Company is engaged in the development of Oncocytes tests and the acquisition of proprietary molecular technologies in the fields of oncology and transplantation. The Company’s products include DetermaIO, VitaGraft, DetermaCNI and GraftAssure. DetermaIO is a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies. DetermaIO measures the expression level of 27 selected genes, which are interpreted through the use of a proprietary algorithm (patent pending) which computes a quantitative score (IO Score) that incorporates information from the immune inflammatory infiltrates within and around the tumor. Its pipeline test, DetermaCNI, is a blood-based monitoring tool for monitoring therapeutic efficacy in cancer patients. VitaGraft is a blood-based solid organ transplantation monitoring test. GraftAssure is a research use only blood-based solid organ transplantation monitoring test.

Organisation	Oncocyte Corp
E-voting on shares	Click here to vote

FAQs

What is Oncocyte Corp share price today?

Oncocyte Corp share price today is $3.17 as on June 18, 2025 at 1:29 am IST at the close of the market. Oncocyte Corp share today touched a day high of $3.17 and a low of $3.17.

What is the 52 week high and 52 week low for Oncocyte Corp share?

Oncocyte Corp share touched a 52 week high of $3.5 on April 25, 2025 and a 52 week low of $2.56 on June 12, 2025. Oncocyte Corp stock price today i.e. June 18, 2025 at 1:29 am IST is closed at $3.17,which is 9.43% down from its 52 week high and 23.83% up from its 52 week low.

How to invest in Oncocyte Corp Stock (OCX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Oncocyte Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Oncocyte Corp Shares that will get you 0.4732 shares as per Oncocyte Corp share price of $3.17 per share as on June 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Oncocyte Corp Stock (OCX) from India?

Indian investors can start investing in Oncocyte Corp (OCX) shares with as little as ₹92.68 or $1 (as of April 4, 2026 at 11:28 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹926.80 in Oncocyte Corp stock (as per the Rupee-Dollar exchange rate as on April 4, 2026 at 11:28 am IST). Based on Oncocyte Corp share’s latest price of $3.17 as on June 18, 2025 at 1:29 am IST, you will get 3.1546 shares of Oncocyte Corp. Learn more about fractional shares .